Clinical Trial Update: New Imaging Biomarkers Predictive of MA Progression [NA]

View source ↗

Summary

Clinical trial exploring ultra-high-field 7 Tesla MR spectroscopy imaging biomarkers to predict progression in Alzheimer's disease; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Poitiers University Hospital | Conditions: Alzheimer Disease, Magnetic Resonance Spectroscopy | NA | Status: RECRUITING